- enrolling by invitation
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
This study is gathering information from people having a procedure called catheter ablation for fast heart rhythms like ventricular tachycardia or frequent extra heartbeats (PVCs). It aims to understand how well this treatment works and to improve care.
United States · Canada · Israel - recruiting
AIC Genotyping Study
This study looks at how certain gene changes might make some people with an irregular heartbeat (Atrial Fibrillation or AF) more likely to develop a weakened heart muscle (heart failure). We're comparing genes in different groups of people to understand this better.
United Kingdom - recruiting
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
This study looks at children and young people up to 18 with a heart condition called cardiomyopathy, caused by a gene change (MYBPC3 mutation). Researchers want to understand how the condition develops, its impact on life, and treatment options. It involves collecting information from their medical records.
United States · Canada · Spain - ongoing, recruitingTherapeutic confirmatory (Phase III)
The efficacy and safety of Metoprolol as add-on treatment to standard of care in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy aged 8-17 years. A randomized, double-blind, placebo controlled study
This study looks at whether a medicine called Metoprolol can help prevent heart problems in young people with Duchenne Muscular Dystrophy. It compares Metoprolol to a dummy medicine to see if it makes a difference to heart strength.
Poland - authorisedTherapeutic confirmatory (Phase III)
A Pilot Study on the Use of Gadopiclenol for Enhanced Cardiac MRI in Children with Congenital Heart Conditions: A self-controlled, non-randomised, open-label study to compare the image quality and diagnostic performance of gadopiclenol versus gadoterate meglumine
This study is looking at a new type of MRI scan for children with congenital heart problems. It compares two different contrast dyes, gadopiclenol and gadoterate meglumine, to see which gives clearer images and helps doctors better understand heart conditions like cardiomyopathy or Tetralogy of Fallot.
Spain